Answer
Daridorexant hydrochloride passes into breast milk in low amounts: in 10 healthy lactating women receiving 50 mg, 0.02% of the maternal dose was excreted into milk; excessive infant sleepiness cannot be excluded, so stopping breastfeeding or Quviviq treatment must be considered based on their respective benefits.
Sources for this answer
- QUVIVIQ 50 mg film-coated tabletsIdorsia Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked